Predicting Evolutionary Potential: In Vitro Evolution Accurately Reproduces Natural Evolution of the TEM ß-Lactamase

Corresponding author: Barry G. Hall, Hutchison Hall, University of Rochester, Rochester, NY 14627-0211., drbh{at}mail.rochester.edu (E-mail)

Communicating editor: G. B. GOLDING

To evaluate the validity of our in vitro evolution method as a model for natural evolutionary processes, the TEM-1 ß-lactamase gene was evolved in vitro and was selected for increased resistance to cefotaxime, cefuroxime, ceftazadime, and aztreonam, i.e., the "extended-spectrum" phenotype. The amino acid substitutions recovered in 10 independent in vitro evolvants were compared with the amino acid substitutions in the naturally occurring extended-spectrum TEM alleles. Of the nine substitutions that have arisen multiple times in naturally occurring extended-spectrum TEM alleles, seven were recovered multiple times in vitro. We take this result as evidence that our in vitro evolution technique accurately mimics natural evolution and can therefore be used to predict the results of natural evolutionary processes. Additionally, our results predict that a phenotype not yet observed among TEM ß-lactamases in nature—resistance to cefepime—is likely to arise in nature.

This article has been cited by other articles:

				A. Novais, R. Canton, T. M. Coque, A. Moya, F. Baquero, and J. C. Galan Mutational Events in Cefotaximase Extended-Spectrum {beta}-Lactamases of the CTX-M-1 Cluster Involved in Ceftazidime Resistance Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2377 - 2382. [Abstract] [Full Text] [PDF]

				J. R. Cochran, Y.-S. Kim, S. M. Lippow, B. Rao, and K.D. Wittrup Improved mutants from directed evolution are biased to orthologous substitutions Protein Eng. Des. Sel., June 1, 2006; 19(6): 245 - 253. [Abstract] [Full Text] [PDF]

				D. M. Weinreich, N. F. Delaney, M. A. DePristo, and D. L. Hartl Darwinian evolution can follow only very few mutational paths to fitter proteins. Science, April 7, 2006; 312(5770): 111 - 114. [Abstract] [Full Text] [PDF]

				R. Fujii, M. Kitaoka, and K. Hayashi RAISE: a simple and novel method of generating random insertion and deletion mutations Nucleic Acids Res., February 21, 2006; 34(4): e30 - e30. [Abstract] [Full Text] [PDF]

				J. Delmas, F. Robin, F. Bittar, C. Chanal, and R. Bonnet Unexpected Enzyme TEM-126: Role of Mutation Asp179Glu Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4280 - 4287. [Abstract] [Full Text] [PDF]

				K. J. Welsh, M. Barlow, F. C. Tenover, J. W. Biddle, J. K. Rasheed, L. A. Clark, and J. E. McGowan Jr. Experimental Prediction of the Evolution of Ceftazidime Resistance in the CTX-M-2 Extended-Spectrum Beta-Lactamase Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1242 - 1244. [Abstract] [Full Text] [PDF]

				S. Haeggman, S. Lofdahl, A. Paauw, J. Verhoef, and S. Brisse Diversity and Evolution of the Class A Chromosomal Beta-Lactamase Gene in Klebsiella pneumoniae Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2400 - 2408. [Abstract] [Full Text] [PDF]

				B. G. Hall In Vitro Evolution Predicts that the IMP-1 Metallo-{beta}-Lactamase Does Not Have the Potential To Evolve Increased Activity against Imipenem Antimicrob. Agents Chemother., March 1, 2004; 48(3): 1032 - 1033. [Abstract] [Full Text] [PDF]

				S. J. Salipante, M. Barlow, and B. G. Hall GeneHunter, a Transposon Tool for Identification and Isolation of Cryptic Antibiotic Resistance Genes Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3840 - 3845. [Abstract] [Full Text] [PDF]

				J.-C. Galan, M.-I. Morosini, M.-R. Baquero, M. Reig, and F. Baquero Haemophilus influenzae blaROB-1 Mutations in Hypermutagenic {Delta}ampC Escherichia coli Conferring Resistance to Cefotaxime and {beta}-Lactamase Inhibitors and Increased Susceptibility to Cefaclor Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2551 - 2557. [Abstract] [Full Text] [PDF]

				M. Barlow and B. G. Hall Experimental Prediction of the Evolution of Cefepime Resistance From the CMY-2 AmpC {beta}-Lactamase Genetics, May 1, 2003; 164(1): 23 - 29. [Abstract] [Full Text] [PDF]

				M. Barlow and B. G. Hall Experimental Prediction of the Natural Evolution of Antibiotic Resistance Genetics, April 1, 2003; 163(4): 1237 - 1241. [Abstract] [Full Text] [PDF]

				S. J. Salipante and B. G. Hall Determining the Limits of the Evolutionary Potential of an Antibiotic Resistance Gene Mol. Biol. Evol., April 1, 2003; 20(4): 653 - 659. [Abstract] [Full Text] [PDF]

				B. G. Hall Predicting Evolution by In Vitro Evolution Requires Determining Evolutionary Pathways Antimicrob. Agents Chemother., September 1, 2002; 46(9): 3035 - 3038. [Abstract] [Full Text] [PDF]